选择(遗传算法)
表达式(计算机科学)
计算机科学
人工智能
计算生物学
Glypican 3型
生物
医学
内科学
癌症
程序设计语言
作者
Ellen Shuhan Meng,Wan‐Teck Lim,Maxime Chénard-Poirier,Jens Samol,Robin Meng,Ying Tong,Yuchen Li,Hong Wang,Paola Fiorentini,Elham Attieh,Qi Tang,Asma Kefsi,Serena Masciari,Giovanni Abbadessa,Cécile Combeau,Lei Tang,Benoit Pasquier,Rui Wang
出处
期刊:
[Mary Ann Liebert, Inc.]
日期:2025-04-30
卷期号:2 (3): 105-116
被引量:1
标识
DOI:10.1089/aipo.2024.0057
摘要
Background:Glypican-3 (GPC3), a cell surface glycoprotein, regulates cell growth and exhibits increased expression in hepatocellular carcinoma (HCC) and squamous non-small cell lung cancer (SQ-NSCLC). This study developed an artificial intelligence (AI) algorithm for predicting GPC3 expression to accelerate clinical trial enrollment, comparing it with manual immunohistochemistry (IHC) scoring. Methods:Using 167 NSCLC and 133 HCC formalin-fixed paraffin-embedded tumor blocks, GPC3 expression was quantified via IHC assays. Machine learning (ML) models were trained on digitized NSCLC whole slide images to identify GPC3-positive tumor areas, applying data-driven cutoffs for classification. Association between GPC3 and programmed cell death-ligand 1 (PD-L1) IHC expression in NSCLC sample was explored. Results:GPC3 expression peaked in HCC (63.9%), followed by SQ-NSCLC (52.6%) and adeno-NSCLC (lung adenocarcinoma) (10.0%). No significant correlation was found between GPC3 and PD-L1 expression in SQ-NSCLC. AI-based screening surpassed clinical pathologists by 10% in precision, achieving 100% recall at a 1% cutoff. ML model quantification aligned well with pathologist consensus. Profiling GPC3 expression emphasized its prevalence in HCC and SQ-NSCLC. Conclusion:Our AI platform standardizes, scales, and reproducibly characterizes GPC3 in NSCLC, supporting patient selection in clinical studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI